Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

| More on:
The Motley Fool

On March 21, there were more developments in the Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) saga.

Most notably, the company announced that CEO Michael Pearson will be stepping down as soon as a successor is found. In addition, activist investor Bill Ackman, head of Pershing Square Capital Management, has now joined the board of directors. And to top it all off, Valeant blamed its past financial misstatements on former CFO Howard Schiller and asked him to resign from the board of directors. Yet he has refused to do so.

While these developments may look like signs of chaos, investors reacted warmly to the news, sending Valeant’s shares up by as much as 17%. So why exactly did Valeant’s shares increase, and what does this news mean for the company in the long term?

Michael Pearson’s departure

Michael Pearson has been the face of Valeant’s rise as well as its fall. It was he who moved the company from the United States to Canada primarily for tax reasons. It was he who slashed Valeant’s R&D spending in favour of an acquisition-based model. And as the company finds itself in a downward spiral, he is at the centre of it all.

Up until March he was still held in very high regard. When the Philidor story dominated headlines, Mr. Ackman reiterated his support for Mr. Pearson. Then when Mr. Pearson had to step down at the end of 2015 (for health-related reasons), Valeant’s share price fell. More recently, Nomura Securities analyst Shibani Malhotra said Valeant would lose its competitive advantage if Mr. Pearson stepped down.

But that all changed when Valeant lowered its 2016 guidance on March 14. Now there’s a sense that the company has no idea what it’s doing, which, of course, reflects badly on the CEO. So it’s no surprise that his departure is being received well.

Bill Ackman’s presence

Not unlike Mr. Pearson, Bill Ackman is another public figure whose reputation has taken a dramatic turn for the worse.

Long known as one of Wall Street’s best activist investors, Mr. Ackman has had some remarkable successes; for example, he initiated the turnaround at Canadian Pacific Railway Limited, which has been a tremendous win for shareholders of that company.

But more recently, the story has been very different. When Valeant started running into trouble, he increased his stake, saying his biggest regret was that he wasn’t in a position to buy more shares. He also said that the company’s biggest problem was poor communication. During a conference call, he even predicted that Valeant’s shares would reach US$448 by 2019.

Yet Mr. Ackman still is held in high regard, so his decision to join the board may be viewed as a small positive.

Howard Schiller

It may seem unfair that Mr. Schiller is being made the scapegoat, since he stepped in as interim-CEO during a very difficult time. Then again, he was CFO at a time when the company misstated its financials.

In any case, this controversy is really more of a side story. Mr. Pearson’s departure was certainly the main reason Valeant’s share price increased, and Mr. Ackman’s increased involvement was likely a factor as well. We’ll have to wait and see how this all plays out.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

dividends can compound over time
Dividend Stocks

2 High-Yield Dividend Stocks That Could Be a Safer Pick for Canadian Retirees

These high-yield dividend stocks are backed by businesses that generate steady cash flow and maintain sustainable payout ratios.

Read more »

House models and one with REIT real estate investment trust.
Dividend Stocks

My 2 Favourite Stocks for Monthly Passive Income

These monthly income-focused Canadian stocks could help investors build a stronger passive-income stream.

Read more »

ETFs can contain investments such as stocks
Dividend Stocks

Investors: Why Many Canadians Aren’t Using Their TFSA the Right Way

Add this dividend-focused Canadian ETF to your TFSA to make the most of the valuable contribution room in your tax-sheltered…

Read more »

Senior uses a laptop computer
Dividend Stocks

Use a TFSA to Make $500 in Monthly Tax-Free Income

Backed by resilient business models, dependable cash flows, and solid long-term growth prospects, these two dividend stocks can generate more…

Read more »

people stand in a line to wait at an airport
Dividend Stocks

Here’s the Average TFSA and RRSP at Age 45

Here’s a stock you can add to your self-directed investment portfolio to cover the gap between your TFSA and RRSP…

Read more »

dividends grow over time
Dividend Stocks

This TSX Dividend Yield Looks Almost Too Good: Here’s What the Numbers Actually Show

This TSX dividend stock's double-digit yield looks credible once you dig into the numbers.

Read more »

middle-aged couple work together on laptop
Energy Stocks

The Average TFSA Balance at 55, and How to Improve Yours

Canadians in their mid-50s can improve their financial standing within 10 years by using their unused TFSA contribution room.

Read more »

monthly desk calendar
Dividend Stocks

2 Monthly Dividend Stocks I’d Buy for Steady Cash Flow

Two dividend stocks are ‘strong buy’ options for investors seeking steady cash flow every month.

Read more »